Geode Capital Management LLC Acquires 4,306 Shares of U.S. Physical Therapy, Inc. $USPH

Geode Capital Management LLC lifted its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.2% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 352,923 shares of the company’s stock after buying an additional 4,306 shares during the quarter. Geode Capital Management LLC owned about 2.32% of U.S. Physical Therapy worth $27,602,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. PNC Financial Services Group Inc. raised its stake in shares of U.S. Physical Therapy by 7.4% in the second quarter. PNC Financial Services Group Inc. now owns 2,949 shares of the company’s stock worth $231,000 after acquiring an additional 203 shares during the last quarter. Huntington National Bank raised its position in U.S. Physical Therapy by 71.9% in the 2nd quarter. Huntington National Bank now owns 667 shares of the company’s stock worth $52,000 after purchasing an additional 279 shares during the last quarter. Bank of New York Mellon Corp raised its position in U.S. Physical Therapy by 4.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock worth $10,288,000 after purchasing an additional 6,190 shares during the last quarter. Atria Investments Inc lifted its holdings in U.S. Physical Therapy by 3.9% during the 2nd quarter. Atria Investments Inc now owns 7,868 shares of the company’s stock worth $615,000 after buying an additional 298 shares in the last quarter. Finally, Assetmark Inc. boosted its position in U.S. Physical Therapy by 35.7% in the 2nd quarter. Assetmark Inc. now owns 570 shares of the company’s stock valued at $45,000 after buying an additional 150 shares during the last quarter.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $73.85 on Friday. The stock has a market cap of $1.12 billion, a PE ratio of 32.25, a price-to-earnings-growth ratio of 4.41 and a beta of 1.47. The stock has a 50-day moving average of $82.39 and a 200-day moving average of $80.03. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. The firm had revenue of $140.66 million during the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. As a group, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 12th. Investors of record on Monday, November 17th will be given a $0.45 dividend. The ex-dividend date is Monday, November 17th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.4%. U.S. Physical Therapy’s dividend payout ratio is currently 75.63%.

Insider Buying and Selling

In other news, COO Eric Joseph Williams sold 1,000 shares of U.S. Physical Therapy stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $85.25, for a total transaction of $85,250.00. Following the transaction, the chief operating officer owned 25,331 shares in the company, valued at $2,159,467.75. The trade was a 3.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nancy Ham sold 600 shares of the business’s stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $81.71, for a total value of $49,026.00. Following the completion of the transaction, the director owned 1,994 shares of the company’s stock, valued at $162,929.74. This represents a 23.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 3,600 shares of company stock valued at $301,336. 2.00% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Sunday, September 21st. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Barrington Research reaffirmed an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a research note on Friday, October 24th. Finally, JPMorgan Chase & Co. lowered their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Monday, November 24th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average target price of $107.75.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.